Axonics Inc. (AXNX)
NASDAQ: AXNX
· Real-Time Price · USD
70.98
null (null%)
At close: Nov 14, 2024, 10:00 PM
Axonics Revenue Breakdown
| Period Ending | Dec 31, 2023 |
|---|---|
| Bulkamid Revenue | 74.57M |
| Bulkamid Revenue Growth | n/a |
| Sacral Neuromodulation Revenue | 291.81M |
| Sacral Neuromodulation Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|
| Non-Us Revenue | 15.54M | 5.13M | 3.75M | 3.99M | 5.44M |
| Non-Us Revenue Growth | +202.88% | +36.69% | -6.01% | -26.65% | n/a |
| United States Revenue | 284.85M | 216.86M | 153.84M | 107.54M | 8.38M |
| United States Revenue Growth | +31.35% | +40.97% | +43.05% | +1183.93% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 76.73M | 67.77M | 71.3M | 66.19M | 59.32M | 54.98M | 54.82M | 54.09M | 49.14M | 49.95M | 43.08M | 40.74M | 36.83M | 33.45M | 27.55M | 24.87M | 22.83M | 19.76M | 24.22M | 21.84M | 20.87M | 15.11M | 9.93M | 4.92M | 3.74M | 2.45M | 1.98M | 1.57M | 1.47M | 1.41M | 1.41M |
| Selling, General, and Administrative Revenue Growth | +13.22% | -4.94% | +7.71% | +11.58% | +7.89% | +0.29% | +1.36% | +10.07% | -1.63% | +15.96% | +5.73% | +10.62% | +10.12% | +21.38% | +10.78% | +8.94% | +15.55% | -18.43% | +10.92% | +4.64% | +38.10% | +52.20% | +101.93% | +31.51% | +52.80% | +23.40% | +26.67% | +6.42% | +4.47% | 0.00% | n/a |
| Research and Development Revenue | 13.49M | 12.79M | 11.06M | 9.71M | 8.17M | 8.95M | 8.06M | 8.1M | 7.94M | 7.13M | 11.24M | 10.18M | 8.65M | 9.1M | 9.37M | 8.14M | 7.75M | 6.4M | 6.88M | 6.23M | 4.86M | 4.87M | 4.22M | 4.78M | 3.9M | 6.18M | 4.54M | 3.37M | 3.13M | 2.91M | 2.91M |
| Research and Development Revenue Growth | +5.46% | +15.70% | +13.82% | +18.94% | -8.74% | +11.08% | -0.58% | +2.10% | +11.23% | -36.50% | +10.35% | +17.74% | -4.95% | -2.89% | +15.10% | +5.06% | +21.10% | -7.06% | +10.44% | +28.38% | -0.39% | +15.53% | -11.79% | +22.70% | -36.91% | +35.99% | +34.69% | +7.70% | +7.51% | 0.00% | n/a |
| Sales and Marketing Revenue | 52.97M | 51.44M | 56.19M | 55.09M | 47.54M | 44.27M | 42.65M | 43.82M | 39.75M | 39.38M | 33.06M | 31.34M | 28.11M | 25.41M | 20.93M | 18.28M | 17.06M | 14.22M | 16.57M | 16.3M | 15.71M | 10.75M | 5.91M | 1.42M | 949K | 811K | 548K | 262.92K | 368K | 199.32K | 199.32K |
| Sales and Marketing Revenue Growth | +2.97% | -8.45% | +1.99% | +15.88% | +7.40% | +3.79% | -2.67% | +10.25% | +0.94% | +19.11% | +5.50% | +11.48% | +10.63% | +21.42% | +14.46% | +7.19% | +19.95% | -14.18% | +1.64% | +3.78% | +46.11% | +81.77% | +317.66% | +49.21% | +17.02% | +47.99% | +108.43% | -28.56% | +84.63% | 0.00% | n/a |